Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jumping Ship: Groupon Insiders Continue Selling Spree

Since it went public, Groupon (NASDAQ:GRPN) has taken a lot of heat for insider selling. The company’s founders took $870 million off the table by the time public investors could buy shares and it’s easy to see now that they were probably cashing in while the company was at its most valuable.

But insider sales haven’t stopped as the flood of Groupon insiders continues to sell shares. Earlier this week, co-founder Bradley Keywell sold another 500,000 shares for a total proceed of $2.7 million and Chief Accounting Officer Brian Stevens sold 47,497 shares, 17% of his stake, for $51,075.

In the last six months, 4.9 million net shares have been sold by Groupon insiders, a huge number for a company that should still be in growth mode.

Another warning sign for the deals company
Groupon reported $49.6 million in losses over the past year and the stock is nearly at a 52-week low of $5.26 per share. Even at that price, insiders don’t see a lot of value in the company and investors should take that as a warning sign. Groupon hasn’t been a great deal since it hit the public market and insider selling has foreshadowed the losses investors have experienced since the company’s IPO.


The next billion-dollar Apple secret
Apple forgot to show you something at its recent event, but a few Wall Street analysts and the Fool didn’t miss a beat: There’s a small company that’s powering Apple’s brand-new gadgets and the coming revolution in technology. And its stock price has nearly unlimited room to run for early-in-the-know investors! To be one of them, just click here.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!